KEY PUBLICATIONS
Neuropeptide S Receptor 1 is a Novel Non-Hormonal Treatment Target in Endometriosis - Tapmeier T. et al, (2021), Science Translational Medicine (click for full text, click for reprint)
Endometriosis - Zondervan KT. et al, (2020), New England Journal of Medicine, 382, 1244 - 1256
The association between endometriosis and autoimmune diseases: a systematic review and meta-analysis - Shigesi N. et al, (2019), Human Reproduction Update
Endometriosis - Zondervan KT. et al, (2018), Nature Reviews Disease Primers, 4
Meta-analysis identifies five novel loci associated with endometriosis highlighting key genes involved in hormone metabolism - Sapkota Y. et al, (2017), Nature Communications, 8
Latest group publications
-
Author Correction: Genome-wide association and epidemiological analyses reveal common genetic origins between uterine leiomyomata and endometriosis.
Journal article
Gallagher CS. et al, (2022), Nat Commun, 13
-
IMI2-PainCare-BioPain-RCT2 protocol: a randomized, double-blind, placebo-controlled, crossover, multicenter trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by non-invasive neurophysiological measurements of human spinal cord and brainstem activity.
Journal article
Leone C. et al, (2022), Trials, 23
-
Human phospho‐signaling networks of SARS‐CoV‐2 infection are rewired by population genetic variants
Journal article
Pellegrina D. et al, (2022), Molecular Systems Biology, 18
-
Letter to the Editor Regarding Systematic review and meta-analysis of the efficacy of gabapentin in chronic female pelvic pain without another diagnosis
Journal article
VINCENT K. et al, (2022), AJOG Global Reports
-
Endometriosis Classification Systems: An International Survey to Map Current Knowledge and Uptake.
Journal article
Zondervan KT. et al, (2022), J Minim Invasive Gynecol
-
Identification of Altered Evoked and Non-Evoked Responses in a Heterologous Mouse Model of Endometriosis-Associated Pain.
Journal article
Tejada MA. et al, (2022), Biomedicines, 10
-
IMI2-PainCare-BioPain-RCT1: study protocol for a randomized, double-blind, placebo-controlled, crossover, multi-center trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by peripheral nerve excitability testing (NET).
Journal article
Nochi Z. et al, (2022), Trials, 23
-
The Cyprus Women’s Health Research (COHERE) initiative: normative data from the SF-36v2 questionnaire for reproductive aged women from the Eastern Mediterranean
Journal article
Swift B. et al, (2022), Quality of Life Research
-
Obesity and risk of female reproductive conditions: A Mendelian randomisation study
Journal article
Venkatesh SS. et al, (2022), PLOS Medicine, 19, e1003679 - e1003679
-
Letter to the Editor Regarding Gabapentin has Longer-Term Efficacy for the Treatment of Chronic Pelvic Pain in Women: A Systematic Review and Pilot Meta-analysis
Journal article
VINCENT K. et al, (2022), Pain and Therapy